| Heading: |
Long Covid: Remdesivir |
| Question ID: |
1805788 |
| UIN: |
54513 |
| House: |
Commons |
| Date tabled: |
2025-05-22 |
| Asking Member ID: |
5256 |
| Asking Member display name: |
Jonathan Davies
|
| Asking Member handle: |
Jonathan4MD
|
| Asking Member Twitter reference: |
@Jonathan4MD
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with the University of Derby on the development of the drug Remdesivir for the treatment of long Covid. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-05 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
We are aware of the University of Derby’s study looking at the use of the drug Remdesivir for the treatment of long COVID, however officials have not discussed the study with the research team. The study is being managed by the University of Plymouth’s Pe... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |